Development of new indicators for the launch of a Japanese version of the NIH (4) : Refined indicators for patents linked with marketed drugs and pipelines

DOI Web Site Web Site 5 Citations 9 References
  • JIBU Mari
    The Organisation for Economic Co-operation and Development (OECD) Institute for Technology, Enterprise and Competitiveness, Japan Science and Technology Agency (JST) Doshisha University
  • OSABE Yoshiyuki
    The Organisation for Economic Co-operation and Development (OECD) Japan Patent Office

Bibliographic Information

Other Title
  • 日本版NIH創設に向けた新しい指標の開発（4）　パイプラインにつながる特許の判別指標
  • ニホンバン NIH ソウセツ ニ ムケタ アタラシイ シヒョウ ノ カイハツ(4)パイプライン ニ ツナガル トッキョ ノ ハンベツ シヒョウ

Search this article

Abstract

For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried to give an overview and future prospects of pharmaceutical industry based on new indicators. Here we show new indicators for identifying patents related with pharmaceutical entities' R&D progress ("Pre-clinical" → "Phase 1" → "Phase 2" → "Phase 3" → "Filed" → "Approved" → "Marketed"). "IPC Count", "Forward Citations", and "Citations to Non-Patent Literature" found as new indicators. Not only pipelines but also patents extracted by new indicators are considered to forecast pharmaceutical industries' power of creating new drugs.

Journal

Citations (5)*help

See more

References(9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top